[Promising results with methylprednisolone in multiple sclerosis. Lack of patent rights makes drug industry less interested].
Kling
Anders
A
Läkemedels Centrum, Norrlands Universitetssjukhus, Umeå. anders.kling@pharm.umu.se
Dahlqvist
Rune
R
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000191:economics; D004345:Drug Industry / Q000191:economics; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D020551:Pulse Therapy, Drug
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone